Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas

Journal of Neuro-Oncology

Volumn 45, Issue 3, 1999, Pages 199-207

  Rushing, Elisabeth J ^a   Colvin, Sarah M ^a   Gazdar, Adi ^a   Miura, Norimasa ^a   White III, Charles L ^a   Coimbra, Caetano ^a   Burns, Dennis K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Papillary meningioma; Proliferation index; Telomerase

Indexed keywords

MONOCLONAL ANTIBODY KI 67; RNA;

ADULT; AGED; ARTICLE; CELL CYCLE PHASE; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MENINGIOMA; PROGNOSIS; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, NEOPLASM; TELOMERASE;

EID: 0033503203     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006353322307     Document Type: Article

References (46)

1. Rachlin JR, Rosenblum ML: Etiology and biology of meningiomas. In: Al-Mefty O (ed) Meningiomas. Raven Press, New York, 1991, pp 22-37
2. Burger PC, Scheithauer BW, Vogel FS: Surgical Pathology of the Nervous System and its Coverings. (3rd edn.). Churchill Livingstone, New York, 1991, pp 79-83
3. Brignolio F, Favero M: Considerations of the malignancy of papillary meningioma: clinico-pathological study of eight cases. Zbl Neurochirurgie 45: 79-84, 1984
4. Cushing H, Eisenhardt L: Meningiomas - Their Classification, Regional Behavior, Life History, and Surgical End Results. Charles C. Thomas, Springfield, II, 1938, pp 692-719
5. Ludwin SK, Rubinstein LJ, Russell DS: Papillary meningioma: a malignant variant of meningioma. Cancer 36: 1363-1373, 1975
6. Stefanko SZ, Mackay WM: Papillary meningiomas. Act Suppl: 126-128, 1981
7. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465, 1997
8. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors : a study with MIB1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54, 1994
9. Moller ML, Braendstrup O: No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34: 241-246, 1997
10. Madsen C, Schroder HD: Ki-67 immunoreactivity in meningiomas - determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67. Clin Neuropathol 16: 137-142, 1997
11. Striepecke E, Handt S, Weis J, Koch A, Cremerius U, Reineke T, Bull U, Schroder JM, Zang KD, Bocking A: Correlation of histology, cytogenetics and proliferation fraction (Ki-67 and PCNA) quantitated by image analysis in meningiomas. Pathol Res Pract 192: 816-824, 1996
12. Langford LA, Cooksley CS, DeMonte F: Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27: 350-354, 1996
13. Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J: Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 48: 501-506, 1997
14. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiyz H, Kirino T: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91: 504-510, 1996
15. Suwa T, Kawano N, Oka H, Ito H, Kameya T: Invasive meningioma: a tumour with high proliferating and 'recurrence' potential. Acta Neurochir 136: 127-131, 1995
16. Kudoh C, Sugiura K, Yoshimizu N, Detta A: Rapidly growing histologically benign meningiomas: cell kinetic and deoxyribonucleic acid ploidy features - report of three cases. Neurosurgery 37: 998-1000, 1995
17. Shay JW, Wright WE, Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072: 1-7, 1991
18. Bodnar AG, Ouelette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352, 1998
19. Greider CW, Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature (London) 337: 331-337, 1989
20. Rhyu MS: Telomeres, telomerase, and immortality. J Natl Cancer Inst 87: 884-894, 1995
21. Shay JW, Werbin H, Wright WE: Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Biol 2: 1-21, 1994
22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994
23. Shay JW, Gazdar A: Telomerase in the early detection of cancer. J Clin Pathol 50: 106-109, 1997
24. Shay JW, Bacchetti S: A survey of telomerase activity in cancer. Eur J Cancer 33: 787-791, 1997
25. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA, Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996
26. Hiyama E, Hiyama K, Yokoyama T, Matsura Y, Piatzszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Medicine 1: 249-255, 1995
27. Hiyama E, Yokoyama T, Tatsumoto N: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995
28. Chadeneau C, Hay K, Hirte HW, Galinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 55: 2533-2536, 1995
29. Sommerfeld H-J, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996
30. Wright WE, Piatyszek MA, Rainey WE et al.: Telomerase activity in human germline and embryonic tissues. Develop Genetics 18: 173-179, 1996
31. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nature Genetics 12: 200-204, 1996
32. Biessman H, Mason JM: Telomere maintenance without telomerase. Chromosoma 106: 63-69, 1997
33. Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Shay JW: Telomerase activity in human brain tumours. Lancet 346: 1267-1268, 1995
34. Nakatani K, Yoshimi N, Mon H, Yoshimura S, Sakai H, Shinoda J, Sakai N: The significant role of telomerase activity in human brain tumors. Cancer 80: 471-476, 1997
35. DeMasters BKK, Markham N, Lillehei KO, Shroyer KR: Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol 107: 548-554, 1997
36. Sallinen P, Miettinen M, Sallinen S-L, Haapasalo H, Helin H, Kononen J: Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol 150: 1159-1164, 1997
37. Rushing EJ, Yashima K, Brown DF, White DL III, Shay JW, Risser RC, Gazdar AF: Expression of telomerase RNA component correlates with MIB-1 proliferation index in ependymomas. J Neuropathol Exp Neurol 56: 1142-1146, 1997
38. Brown DF, Gazdar A, White CL III, Yashima K, Shay JW, Rushing EJ: Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinomas. J Neuropathol Exp Neurol 56: 1349-1355, 1997
39. Langford LA, Piatyszek MA, Xu R, Schold SC, Wright WE, Shay JW: Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 28: 416-420, 1997
40. Kleihues P, Burger PC, Scheithauer BW: World Health Organization International Histological Classification of Tumors. (2nd edn.). Springer Verlag, New York, 1993, pp 33-37
41. Yashima K, Piatyszek MA, Saboorian HM, Virmani AK, Brown D, Shay JW, Gazdar AF: Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin pathol 50: 110-117, 1997
42. Shuangshoti S: Primary papillary meningiomas of the optic nerve sheath: a case of unique location and benign pathology. Surg Neurol 39: 200-203, 1998
43. Pasquier B, Gasnier F, Pasquier D, Keddari E, Morens A, Coudrec P: Papillary meningioma: clinicopathologic study of seven case and review of the literature. Cancer 58: 229-305, 1986
44. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handu J: Meningiomas: proliferating potential and clinicoradiological features. Neurosurgery 37: 1049-1055, 1995
45. Yashima K, Ashfaq R, Nowak J, Gruenigen VV, Milchgrub S, Rathi A, Albores-Saavedra J, Shay JW and Gazdar A: Telomerase activity and expression of its RNA component in cervical lesions. Cancer 82: 1319-1327, 1998
46. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II et al.: Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinoma. Cancer Research 57: 2373-2377, 1997